tegafur has been researched along with Chronic Kidney Failure in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tegafur is a well-known prodrug of 5-FU." | 1.42 | [A Case Report of Successful Chemotherapy with Tegafur/Gimeracil/Oteracil and Nab-Paclitaxel for Gastric Cancer with Chronic Renal Failure]. ( Kurashima, Y; Miyazaki, T; Ohata, K; Ohno, K; Okawa, M; Tanaka, S; Uenishi, T; Yamamoto, T, 2015) |
| "A 61-year-old man on hemodialysis due to chronic renal failure caused by diabetes mellitus was diagnosed as having ascending colon cancer with multiple liver metastases." | 1.38 | [A case of stage IV colon cancer effectively treated with tegafur uracil/calcium folinate in a patient on hemodialysis]. ( Kobayashi, M; Maeda, H; Okamoto, K; Takeshita, A, 2012) |
| " No severe adverse effects of more than grade 3 were encountered." | 1.37 | [Palliative anti-cancer chemotherapy is safely executable in a hemodialytic patient with unresectable advanced gastric cancer]. ( Hosojima, Y; Miura, T; Nakamura, J; Nakazawa, Y; Ozeki, Y; Takahashi, T; Yamada, S; Yamazaki, H; Yanagi, M, 2011) |
| " S-1 has safe and potent antitumor effects in patients with gastric cancer via these respective functions." | 1.32 | Safety and efficacy of S-1, a novel oral fluorouracil antitumor drug, for a chronic renal failure patient maintained on hemodialysis. ( Arakawa, T; Fujiwara, Y; Hamaguchi, M; Higuchi, K; Matsumoto, T; Okazaki, H; Oshitani, N; Sasaki, E; Shiba, M; Suto, R; Tanigawa, T; Tominaga, K; Watanabe, T, 2004) |
| "Mitomycin C (MMC) is an alkylating agent which has been associated with microangiopathic hemolytic anemia and acute renal failure, with an overall incidence between 2 and 10%." | 1.28 | Silent renal microangiography after mitomycin C therapy. ( Botey, A; Darnell, A; González-Clemente, JM; Poch, E; Revert, L; Torras, A, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamamoto, T | 1 |
| Miyazaki, T | 1 |
| Kurashima, Y | 1 |
| Ohata, K | 1 |
| Okawa, M | 1 |
| Tanaka, S | 1 |
| Uenishi, T | 1 |
| Ohno, K | 1 |
| Miura, T | 2 |
| Hosojima, Y | 1 |
| Nakamura, J | 1 |
| Yamada, S | 1 |
| Nakazawa, Y | 1 |
| Ozeki, Y | 1 |
| Yanagi, M | 1 |
| Yamazaki, H | 1 |
| Takahashi, T | 1 |
| Okamoto, K | 1 |
| Kobayashi, M | 1 |
| Maeda, H | 1 |
| Takeshita, A | 1 |
| Tominaga, K | 1 |
| Higuchi, K | 1 |
| Okazaki, H | 1 |
| Suto, R | 1 |
| Hamaguchi, M | 1 |
| Tanigawa, T | 1 |
| Sasaki, E | 1 |
| Shiba, M | 1 |
| Watanabe, T | 1 |
| Fujiwara, Y | 1 |
| Oshitani, N | 1 |
| Matsumoto, T | 1 |
| Arakawa, T | 1 |
| Tanaka, T | 1 |
| Fujita, S | 1 |
| Tanaka, N | 2 |
| Ooka, M | 1 |
| Okajima, S | 1 |
| Sakamoto, K | 1 |
| Arita, S | 1 |
| Hisikawa, E | 1 |
| Yaguchi, H | 1 |
| Arima, H | 1 |
| Matsumoto, M | 1 |
| Hachisu, T | 1 |
| Kashiwabara, H | 1 |
| Yokoyama, T | 1 |
| Yanagisawa, T | 1 |
| Arimoto, T | 1 |
| Kishimoto, H | 1 |
| Takahashi, Y | 1 |
| Urade, M | 1 |
| Yoshioka, W | 1 |
| Poch, E | 1 |
| González-Clemente, JM | 1 |
| Torras, A | 1 |
| Darnell, A | 1 |
| Botey, A | 1 |
| Revert, L | 1 |
1 trial available for tegafur and Chronic Kidney Failure
| Article | Year |
|---|---|
[Pharmacokinetic study of UFT in cancer patients receiving maintenance dialysis].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva | 1995 |
7 other studies available for tegafur and Chronic Kidney Failure
| Article | Year |
|---|---|
[A Case Report of Successful Chemotherapy with Tegafur/Gimeracil/Oteracil and Nab-Paclitaxel for Gastric Cancer with Chronic Renal Failure].
Topics: Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Kidney | 2015 |
[Palliative anti-cancer chemotherapy is safely executable in a hemodialytic patient with unresectable advanced gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Docetaxel; Humans; Irinotecan; K | 2011 |
[A case of stage IV colon cancer effectively treated with tegafur uracil/calcium folinate in a patient on hemodialysis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms; Combined Modality Ther | 2012 |
Safety and efficacy of S-1, a novel oral fluorouracil antitumor drug, for a chronic renal failure patient maintained on hemodialysis.
Topics: Administration, Oral; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Kidney | 2004 |
[TS-1 treatment for progressive gastric cancer in a patient on chronic dialysis--assessment of dosage regimen by monitoring blood concentrations of therapeutic drugs (TDM)].
Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Area Under Curve; Drug Administration Schedu | 2005 |
[Dynamic change of serum UFT concentration in a patient with tongue cancer complicating chronic renal failure].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell | 1995 |
Silent renal microangiography after mitomycin C therapy.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Human | 1990 |